Human glutaminyl-tRNA synthetase (QRS) is one of several mammalian aminoacyl-tRNA synthetases (ARSs) which form a macromolecular protein complex.
aprotinin, and 5 µg/ml TPCK). Resuspended cells were lysed by gentle sonication and centrifuged at 33,000 x g for 20 min, at 4°C. Protein concentration was determined by Bradford assay. Twenty micrograms of cell lysate was mixed with reaction buffer (50 mM HEPES, pH 7.5, 20 mM KCl, 25 mM MgCl 2 , 20 mM β-mercaptoethanol, 0.2 mg/ml bovine serum albumin, 5 mM ATP, and 0.12 µCi/µl [ 3 H]-glutamine), and the reaction was initiated by adding bovine liver total tRNA (0.4 µg/µl). Reaction samples were taken at 1.3-minute intervals and spotted on filter discs presoaked with 5% trichloroacetic acid. After 1 minute, the filter discs were added to ice-cold 5% trichloroacetic acid and washed three times with fresh 5% trichloroacetic acid at 4°C.
The filter discs were dehydrated by incubation with 95% ethanol at 4°C and the radioactivity adsorbed to the filters was quantitated by liquid scintillation counting.
Gel filtration chromatography-Cell lysate (5 mg of total protein) in hypotonic buffer
was loaded into a Superdex 200 HR column (exclusion limit of 1,300 kDa) using AKTA-FPLC (Amersham Pharmacia Biotech, UK) and eluted at the flow rate of 0.2 ml/min. 50 µl of each fraction (0.3 ml) was analyzed by immunoblotting using antibodies against Myc, EPRS, IRS, LRS, MRS, QRS, p43, and p38 as indicated.
Results

QRS catalytic domain alone was incorporated to the multi-ARS complex-We compared
QRS sequences from E. coli , yeast, and human in an attempt to identify a domain of QRS which would target it to the multi-ARS complex. As shown in Fig. 1 In order to map the domain of QRS targeting it to the multi-ARS complex, we constructed various Myc epitope-tagged deletion mutants of QRS. The mutant QRS constructs used in this study are shown schematically in Fig. 2A . QRS-N and -C represent the appended or catalytic domain, respectively. The constructs were transiently overexpressed in 293 cells and cell lysates were immunoprecipitated with anti-Myc antibody. The precipitated complex was immunoblotted using a mixture of antibodies specific to EPRS, LRS, MRS, QRS, RRS, YRS, WRS, and p43. Fig. 2B shows that QRS-F and -C were co-immunoprecipitated with the EPRS, LRS, MRS, RRS, and p43 components of the multi-ARS complex, while QRS-N was not. Cells were then transiently transfected with expression vectors for Myc-GRS and -CRS, which are known not to be associated with the multi-ARS complex (1). As above, lysates were immunoprecipitated with anti-Myc antibody and then immunoblotted with the antibody mixture. No components of the multi-ARS complex were detected in association with either Myc-GRS or -CRS, thus confirming the specificity of multi-ARS complex interactions with QRS-F and -C. In addition, Amido Black staining of the membrane also confirmed that the immunoprecipitates of QRS-F and QRS-C contained bands corresponding to EPRS, IRS, LRS, MRS, RRS, and p43 whereas QRS-N did not (Fig. 2C) . Interestingly, QRS could be present as an oligomer in the multi-ARS complex since QRS-C also co-immunoprecipitated endogenous QRS (endogenous QRS is indicated with an arrowhead in Fig. 2B and 2C ). This data suggests that QRS-C and endogenous QRS could co-exist in the multi-ARS complex.
In order to map the region of QRS-C interacting with the multi-ARS complex, different Myc-tagged QRS derivatives were transiently expressed and immunoprecipitated with anti-Myc. As shown Fig. 3 , QRS (1-552), and QRS were co-immunoprecipitated with the multi-ARS complex while QRS (458-775) was not, suggesting that the region from amino acids 237 to 457 is necessary for QRS targeting to the multi-ARS complex. Furthermore, the QRS derivatives, QRS (∆380-568) and QRS (∆179-653), which also do not contain amino acids 380 to 568,
were not targeted to the multi-ARS complex. Indeed, QRS deletion mutants containing the amino acid regions 237 to 457, and 237 to 552, were all incorporated into the multi-ARS complex (Fig. 3) . These mapping data demonstrate that the region of QRS from amino acids 237 to 457 is a domain needed to target QRS to the multi-ARS complex. This region is an ATP binding domain that is called Rossman fold (16).
Thus, our data indicates that the Rossman fold is necessary for protein-protein interaction within the multi-ARS complex. 
QRS appended domain is essential for aminoacylation activity-
QRS appended domain is required for association of other components in the multi-ARS
complex-The incorporation of QRS-C into the multi-ARS complex was also confirmed by gel filtration chromatography using FPLC ( immunoblotted with anti-Myc antibody, the overexpressed QRS-F was though to be largely incorporated into the multi-ARS complex. Like the profile of endogenous QRS protein, its enzymatic activity was also found in both the free form as well as in the multi-ARS complex (Fig. 5B) , suggesting that association with the multi-ARS complex is not essential for the catalytic activity of QRS.
When cells transfected with QRS-C were analyzed for both QRS-C and endogenous QRS using immunoblotting with anti-Myc and anti-QRS antibodies after gel filtration, we found that QRS-C was targeted to the multi-ARS complex (Fig. 5A) , consistent with the result of co-immunoprecipitation experiment in Fig. 2 . Interestingly, a portion of endogenous QRS was also present in the free form, as well as the multi-ARS complex,
suggesting that QRS-C replaces endogenous QRS in the multi-ARS complex. Since QRS-C did not change the aminoacylation activity of endogenous QRS (Fig. 4) , the free endogenous QRS still appears to have enzymatic activity. into the complex caused the release of both RRS, and p43 (Fig. 6B) , suggesting that the absence of QRS N-terminal appendix in the multi-ARS complex disrupts the association of RRS and p43 within the complex. On the other hand, EPRS, IRS, LRS, MRS, and p38 were not released to the free forms from the multi-ARS complex, suggesting that these components were not affected by the absence of the QRS N-terminal appendix.
Thus, we conclude that the catalytic domain of QRS is required for targeting QRS to the multi-ARS complex, while its appended domain is necessary for the stabilization of RRS and p43 within the multi-ARS complex.
Discussion
We have previously mapped the protein-protein interactions between various peptide domains of the ARSs that are components of the multi-ARS complex (6). We also show that the QRS N-terminal appendix is required for enzymatic activity of QRS (Fig. 4) . In many other ARSs, this domain is dispensable for cell survival and aminoacylation activity. The appended domain of QRS was responsible for targeting RRS and p43 into the multi-ARS complex (Fig. 6 ). When QRS-C was overexpressed, it was incorporated into the multi-ARS complex while endogenous QRS, RRS, and p43 were removed from this complex, instead being found in free forms (Fig. 6) . Thus, the removal of the N-terminal appendix disrupts molecular interactions among QRS, RRS, and p43 within a multi-ARS complex, releasing RRS and p43. It should be noted that previously yeast two hybrid analysis has shown molecular association of QRS with RRS (6), and RRS with p43 via the appended domains (7). Since QRS-C overexpression does not affect other ARSs such as EPRS, IRS, LRS, MRS, and p38 (Fig. 6) , the appended domain of QRS might have a stabilizing role in maintaining RRS and p43 in the multi-ARS complex.
Taken together, the data of this work suggest that the catalytic domains of the complex-forming ARSs play an important role in protein-protein interactions within the macromolecular ARS complex. This finding poses an interesting question on the architecture of the complex because it is intriguing how the component ARSs would execute their catalytic activities while their catalytic domains are involved in complex association.
Abbreviations:
Aminoacyl-tRNA synthetase, ARS; XRS, ARS for amino acid X. 
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